Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.628 USD | -0.32% | -11.54% | -87.20% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.20% | 2.32M | |
+2.01% | 42.59B | |
+8.25% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.10% | 24.81B | |
-24.25% | 18.17B | |
+27.24% | 12.05B | |
-3.25% | 11.7B | |
+6.92% | 11.1B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Maxim Starts Quoin Pharmaceuticals at Buy with $5 Price Target